Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study.

dc.contributor.author

Lei, Xun

dc.contributor.author

Huang, Ke

dc.contributor.author

Liu, Qin

dc.contributor.author

Jie, Yong-Feng

dc.contributor.author

Tang, Sheng-Lan

dc.coverage.spatial

England

dc.date.accessioned

2017-12-01T14:16:47Z

dc.date.available

2017-12-01T14:16:47Z

dc.date.issued

2016-05-05

dc.description.abstract

BACKGROUND: Tuberculosis (TB) patients face numerous difficulties adhering to the long-term, rigorous TB treatment regimen. Findings on TB patients' treatment adherence vary across existing literature and official reports. The present study attempted to determine the actual treatment adherence of new TB patients and to identify factors leading to non-adherence. METHODS: A prospective cohort of 481 newly confirmed TB patients from three counties in western China were enrolled during June to December 2012 and was followed until June 2013. Patients who missed at least one dose of drugs or one follow-up re-examination during the treatment course were deemed as non-adherent. Influencing factors were identified using a logistic regression model. RESULTS: A total of 173 (36.0 %) patients experienced non-adherence and the loss to follow-up cases reached 136 (28.2 %). Only 13.9 % of patients took drugs under direct observation, and 60.5 % of patients were supervised by phone calls. Factor analyses suggested that patients who were observed by family members (OR:5.54, 95 % CI:2.87-10.69) and paying monthly service expenses above 450 RMB (OR:2.08, 95 % CI:1.35-3.19) were more likely to be non-adherent, while supervision by home visit (OR:0.06, 95 % CI:0.01-0.28) and phone calls (OR:0.27, 95 % CI:0.17-0.44) were protective factors. CONCLUSIONS: Despite recent efforts, a large proportion of newly confirmed TB patients could not adhere to standard TB treatment, and patients' lost to follow-up was still a serious problem. Poor treatment supervision and heavy financial burden might be the main causes for non-adherence. More needs to be done to enhance treatment supervision policies and financial supports to both health providers and TB patients.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/27146470

dc.identifier

10.1186/s40249-016-0134-9

dc.identifier.eissn

2049-9957

dc.identifier.uri

https://hdl.handle.net/10161/15794

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Infect Dis Poverty

dc.relation.isversionof

10.1186/s40249-016-0134-9

dc.subject

Adherence

dc.subject

China

dc.subject

Prospective cohort study

dc.subject

Tuberculosis

dc.subject

Adolescent

dc.subject

Adult

dc.subject

Aged

dc.subject

Aged, 80 and over

dc.subject

Antitubercular Agents

dc.subject

China

dc.subject

Female

dc.subject

Humans

dc.subject

Lost to Follow-Up

dc.subject

Male

dc.subject

Medication Adherence

dc.subject

Middle Aged

dc.subject

Patients

dc.subject

Prospective Studies

dc.subject

Tuberculosis

dc.subject

Young Adult

dc.title

Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study.

dc.type

Journal article

duke.contributor.orcid

Tang, Sheng-Lan|0000-0001-6462-753X

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/27146470

pubs.begin-page

38

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

School of Medicine

pubs.organisational-group

Temp group - logins allowed

pubs.publication-status

Published online

pubs.volume

5

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study.pdf
Size:
502.59 KB
Format:
Adobe Portable Document Format
Description:
Published version